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j Summary: This paper describes a rapid and accurate method for determining binding abilities of thyroid
\ hormones to their corresponding serum proteins: prealbumin, albumin and thyroxine binding globulin. A
tube cell agarose gel electrophoresis is used with radioactive labelled triiodothyronine or thyroxine. The
distribution curve shows characteristic peaks for prealbumin, albumin and thyroxine binding globulin.
A collective of 60 euthyroid thyroid-healthy persons was examined, and the following reference values for
the binding of thyroxine to its binding proteins were found: The percentage binding of thyroxine to the
prealbumin fraction is 21 to 33%, to the albumin fraction 10 to 15% and to the thyroxine binding globulin
fraction 54 to 66%. In a group of 220 patients with suspected thyroid hormone binding abnormalities there
were 42 cases of albumin-associated hyperthyröxinaemia, 5 cases of prealbumin-associated hyperthyroxina-
emia and 2 cases of thyroxine binding globulin deficiency. In another group of 35 patients with suspected
antibodies against thyroid hormones one patient showed antibodies against triiodothyronine.
Thyroxine binding globulin (TBG) elevations during
Today, several thyroid hormone binding abnormali- pregnancy or oral contraceptioii, familial thyroxine
ties are known. binding globulin excess with X-linked inheritance (9)
A1v . · j t. t. · · r- j and thyroxine binding globulin deficiency (10) haveAlbumin-associated hyperthyroxmaemia was first de- - ., ,
scribed in 1979 (l -^6). The genetic studies show an aescnbed.
autosomal-dominant inheritance called FDH syn- Another binding abnormality concerns the binding
drome (familiär dysalbuminaemic hyperthyroxinae- of triiodothyronine (Ta) and thyroxine (T4) to anti-
mia). The syndrome is chäracterized by an increase bodies of the IgG class (11). On the whole, the occur-
in serum total thyröxine (TT4), the free thyroxine rence of thyroid hormone antibodies is rare and usu-
index (FT4I) and elevated free T4 (fT4) measufed by ally föund in patients with Hashimoto thyreoiditis,
analogüe tracer, due to an abnormal serum albumin thyroid cancer and Graves' disease. In these cases
which preferentiälly binds thyroxine. The euthyroid there is a 70% occurrence of antibodies against T3,
state is chäracterized by a normal ft4 (determined by 20% of antibodies against T3 and T4 and 10% of
equilibrium dialysis) and by a normal serum thyrötro- antibodies against T4 only (12).
Pin (TSH) response to thyroliberin (TRH). ^^ alterations in thyrpxine binding proteins lead
A thyroxine binding abnormality for prealbumin to changes in thyroid function tests resulting in er-
(TBPA) was subsequently reported by Moses et al. roneous diagnosis of thyroid dysfunction in euthyroid
1982 (7) and Lalloz et al. 1984 (8). individuals. It is therefore very important to deter-
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mine the binding of T3 and T4 to their binding pro-
teins thyroxine binding prealbumin, albumin and thy-
roxine binding globulin.
The object of our work was the development of a
rapid and accurate new method, applicable in a
routine laboratory, for the determination of thyroid
hormone binding to serum proteins.
Radioelectrophoresis for determination of thyroid
hormone antibodies
Serum (100 μΐ) and 1.5 mg 8-anilinonaphthalene-l-sulphonic
acid ammonium salt (ANS) are incubated with 10 μΐ radioactive
labelled T3 or T4 for 24 hours at room temperature. Radioelec-
trophoresis is then carried out s described above.
Results
After electrophoresis the gel shows one band which
represents the bromphenol blue-stained albumin. The
region between albumin and the origin contains the
thyroxine binding globulin and the region anodal to
albumin contains the thyroxine binding prealbumin.
The radiogram of the gel shows peaks for thyroxine







[125I]thyroxine solution (L M. 141) and [12SI]triiodothyronine "-5
solution (L M. 321) were obtained from Amersham (G. B.), °
agar purum from Behring (West Germany). All other reagents
were purchased from Merck (West Germany) and were of
analytical grade.
Methods
Radioelectrophoresis for determination of thyroxine
binding to Jhyroxine binding prealbumin, albumin
and thyroxine binding globulin
Fresh or deep frozen serum (100 μΐ) is incubated with 10 μΐ
radioactive labelled T4 for l hour at room temperature. To
stain the albumin, the sera are mixed with 5 μΐ of a saturated
aqueous bromphenol blue solution. For the preparation of
agarose gel, 9 g agar purum are dissolved in one liter of the
following buffer:
0.17 mol/1 glycine, 0.13 mol/1 acetic acid, 0.14 mol/1 sodium
hydroxide, 3.1 mmol/1 sodium azide, pH 8.6.
The agarose gel is poured into gel tubes. The glass gel tubes
used were of 5 mm interior diameter and 7 cm length (Bio
Rad, USA). The bottom of the tubes are closed by a dialysis
membrane to prevent the gels from slipping out. Serum (5 μΐ)
is applied to the gel. Electrophoresis is performed in the same
buffer s described above at 15 mA per tube for 105 minutes.
(Tube cell electrophoresis with cooling core by Bio Rad, type
175). After electrophoresis, the gels are cut into 20 slices of 2
to 3 mm width each, and the radioactivity of each slice is
measured in a gamma counter. The slice number is plotted (χ?·








Fig. 1. Normal distributipn curve with reference ranges f thy^
roxine binding to prealbumin (PA), albumin (A) and
thyroxine binding globulin (TBG).
globulin (fig. 1). The mimber of counts under each
peak shows the binding of radioactive-labelled T4 to
thyroxine binding prealbumin, albumin and thyro-
xine binding globulin in per cent of the total radioac-
tivity.
In the presence of 8-anilinonaphthalene-l-sulphomc
acid, thyroid hormone binding to thyroxine binding
globulin is suppressed and the binding equilibrium
shifts to the thyroid honnone antibodies. A normal
distribution curve of T3 incubated with 8-anilinpna-
phthalene-1-sulphonic acid shows only one albumin
peak (fig. 5). In the case of T3 antibodies the radio-
gram shows one peak for albumin-bound T3 and one
peak in the area of the γ-globulin fraction (fig. 6).
In the case of T4 antibodies, a thyroxine binding
prealbumin peak, an albumin peak and a peak in the
area of the γ-globulin fraction are seen.
In order to define normal binding patterns of thyroid
hormones to their binding proteins, 60 euthyroid
thyroid-healthy persons were examined using this
new method. The percentage binding of thyroxine
to thyroxine binding prealbumin is 21 to 33%, for
albumin 10 to 15% and for thyroxine binding globu-
lin 54 to 66% (fig. 1).
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Fig. 2. Albumin-associated hyperthyroxinaemia:
binding of thyroxine to albumin (A) is clearly increased
at 27%, while binding to prealbumin (PA) is in the
normal ränge, and binding to thyroxine binding globu-
















Fig. 3. Prealbumin-associated hyperthyroxinaemia:
thyroxine binding to prealbumin (PA) is clearly in-
creased, while binding to albumin (A) is in the lower
normal ränge; percentage binding to thyroxine binding
globulin (TBG) below reference value at 48%.
Furthermore, 220 patients with suspected binding
abnormalities were examined.
In 42 cases, an increased binding of T4 to albumin
(FDH-syndrome) was found. The percentage binding
of T4 to albumin was between 19 and 39%. The mean
Value was 25.5 ± 4.9% (fig. 2). In connection with
albumin-associated hyperthyroxinaemia it is impor-
tant to examine the entire family because of autoso-
mal dominant inheritance. Of the 42 cases cited
above, 24 belonged to 11 families, and 32 members
of these families were examined. Thyroxine binding
pfealbumin-associated hyperthyroxinaemia is rare.
Among the same group of patients 5 cases were
found. Three cases came from one family. The two
others were sporadic. The values of T4 bound to
thyroxine binding prealbumin were between 36 and
43% with .a mean value of 39.6 ± 2.9% (fig. 3).
Finally, two cases of thyroxine binding globulin defi-
ciency were found in this collective. Most of the T4
is bound to thyroxine binding prealbumin, the rest
to albumin: thyroxine binding prealbumin 89%, albu-
min 11% and thyroxine binding globulin 0% (fig. 4).
Among the 35 patients with suspected antibodies
against thyroid hormones there was one case with




Fig. 4. Thyroxine binding globulin (TBG) deficiency:
thyroxine is bound to prealbumin (PA) at 89% and to
albumin (A) at 11%; there is no peak for thyroxine
binding globulin (TBG).
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Fig. 5. Normal distribution curve for serum incubated with
triiodothyronine and 1.5 mg 8-anilinonaphthalene-l-
sulphonic acid:
The normal curve shows one peak of triiodothyronine
bound to albumin (A). The binding of triiodothyronine














Fig. 6. Antibodies against triiodothyronine:
The serum incubated with triiodothyronine and 1.5 mg
8-anilinonaphthalene-l-sulphonic acid shows an albu-
min peak (A) and one peak in the -globulin fraetion
corresponding to triiodothyronine bound to antibodies
(AB).
Discussion
Several methods for measurement of thyroxine bind-
ing proteins have been developed. Early attempts
with conventional paper electrophoresis failed be-
cause of poor Separation of the thyroxine binding
proteins, and the occurrence of artefacts due to the
adsorption of albumin-bpund thyroxine on the filter
paper. The method was modified by the use of re-
versed flow zone electrophoresis (13), in which the
hydrodynamic flow of buffer opposed the migration
of albumin, so that thyroxine binding prealbumin
and thyroxine binding globulin were better separated
from the albumin. But the technique is tiine-consum-
ing and the Separation is not satisfactory. A better
Separation was achieved by agaf ose gel electrophore-
sis. Doctor et al. 1981 (14) described this technique
in agaf ose gel on microscope slides. A great disadvan-
tage of this method is the necessity for cooling by
immersing the slides in petroleum spirit. A second
problem is cutting the thin gel into separate sections
for counting. These difficulties are largely eliminated
by usiiig tube cell agarose gel electrophoresis. Com-
plete Separation of the binding proteins is obtained
in less than two hours. The cooling of the gels is
achieved by the large buffer volume and the water
cooling core in the Instrument. It is no problem to
cut the gel column into several slices for counting.
The normal binding pattern of thyroid hormones to
their binding proteins determined by this method
does not correspond to values obtained by paper
reversed flow zone electrophoresis (3). The results
obtained by our method are highly reproducible äs
assessed by multiple analyses of the same serum sam-
ple (results not shown). In clinical practice the de-
scribed method of binding electrophoresis is an im-
portant aid in the diagnosis of euthyroidism. Patients
with binding abnormalities show changes in thyroid
function tests including increases in TT4, FT4I and
analogue fT4· As a result of misdiagnosis of hjrperthy-
reosis by use of these conventional methods, 7 of our
patients with FDH syndrome underwent surgery or
received radio-iodine treatment. Since binding abnor-
malities are inheritable it is necessary to examine a
patient's relatives to prevent misdiagnosis and mis-
therapy. Such errors have been avoided sinee the
introduction of this new method in röutine laboratör-
ies.
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